Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease

Andrea Taddio, Alberto Tommasini, Erica Valencic, Ettore Biagi, Giuliana Decorti, Sara De Iudicibus, Eva Cuzzoni, Giuseppe Gaipa, Raffaela Badolato, Alberto Prandini, Andrea Biondi, Alessandro Ventura

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSC) are cells of stromal origin which exhibit unlimited self-renewal capacity and pluripotency in vitro. It has recently been observed that MSC may also exert a profound immunosuppressive and anti-inflammatory effect both in vitro and in vivo with consequent potential use in autoimmune disorders. We present the case of a patient suffering from childhood-onset, multidrug resistant and steroiddependent Crohn's disease who underwent systemic infusions of MSC, which led to a temporary reduction in CCR4, CCR7 and CXCR4 expression by T-cells, and a temporary decrease in switched memory B-cells, In addition, following MSC infusion, lower doses of steroids were needed to inhibit proliferation of the patient's peripheral blood mononuclear cells. Despite these changes, no significant clinical benefit was observed, and the patient required rescue therapy with infliximab and subsequent autologous hematopoietic stem cell transplantation. The results of biological and in vitro observations after MSC use and the clinical effects of infusion are discussed, and a brief description is provided of previous data on MSC-based therapy in autoimmune disorders.

Original languageEnglish
Pages (from-to)4379-4384
Number of pages6
JournalWorld Journal of Gastroenterology
Volume21
Issue number14
DOIs
Publication statusPublished - Apr 14 2015

Fingerprint

Mesenchymal Stromal Cells
Crohn Disease
Interferons
Therapeutics
Hematopoietic Stem Cell Transplantation
Immunosuppressive Agents
Stromal Cells
Cell- and Tissue-Based Therapy
Blood Cells
B-Lymphocytes
Anti-Inflammatory Agents
Steroids
T-Lymphocytes
In Vitro Techniques

Keywords

  • Autoimmune disease
  • Crohn's disease
  • Immune regulation
  • Interferon-γ
  • Mesenchymal stem cells
  • Pretreatment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease. / Taddio, Andrea; Tommasini, Alberto; Valencic, Erica; Biagi, Ettore; Decorti, Giuliana; De Iudicibus, Sara; Cuzzoni, Eva; Gaipa, Giuseppe; Badolato, Raffaela; Prandini, Alberto; Biondi, Andrea; Ventura, Alessandro.

In: World Journal of Gastroenterology, Vol. 21, No. 14, 14.04.2015, p. 4379-4384.

Research output: Contribution to journalArticle

Taddio, Andrea ; Tommasini, Alberto ; Valencic, Erica ; Biagi, Ettore ; Decorti, Giuliana ; De Iudicibus, Sara ; Cuzzoni, Eva ; Gaipa, Giuseppe ; Badolato, Raffaela ; Prandini, Alberto ; Biondi, Andrea ; Ventura, Alessandro. / Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease. In: World Journal of Gastroenterology. 2015 ; Vol. 21, No. 14. pp. 4379-4384.
@article{3d7657f1389b4f45a608cf868edde63d,
title = "Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease",
abstract = "Mesenchymal stem cells (MSC) are cells of stromal origin which exhibit unlimited self-renewal capacity and pluripotency in vitro. It has recently been observed that MSC may also exert a profound immunosuppressive and anti-inflammatory effect both in vitro and in vivo with consequent potential use in autoimmune disorders. We present the case of a patient suffering from childhood-onset, multidrug resistant and steroiddependent Crohn's disease who underwent systemic infusions of MSC, which led to a temporary reduction in CCR4, CCR7 and CXCR4 expression by T-cells, and a temporary decrease in switched memory B-cells, In addition, following MSC infusion, lower doses of steroids were needed to inhibit proliferation of the patient's peripheral blood mononuclear cells. Despite these changes, no significant clinical benefit was observed, and the patient required rescue therapy with infliximab and subsequent autologous hematopoietic stem cell transplantation. The results of biological and in vitro observations after MSC use and the clinical effects of infusion are discussed, and a brief description is provided of previous data on MSC-based therapy in autoimmune disorders.",
keywords = "Autoimmune disease, Crohn's disease, Immune regulation, Interferon-γ, Mesenchymal stem cells, Pretreatment",
author = "Andrea Taddio and Alberto Tommasini and Erica Valencic and Ettore Biagi and Giuliana Decorti and {De Iudicibus}, Sara and Eva Cuzzoni and Giuseppe Gaipa and Raffaela Badolato and Alberto Prandini and Andrea Biondi and Alessandro Ventura",
year = "2015",
month = "4",
day = "14",
doi = "10.3748/wjg.v21.i14.4379",
language = "English",
volume = "21",
pages = "4379--4384",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "14",

}

TY - JOUR

T1 - Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease

AU - Taddio, Andrea

AU - Tommasini, Alberto

AU - Valencic, Erica

AU - Biagi, Ettore

AU - Decorti, Giuliana

AU - De Iudicibus, Sara

AU - Cuzzoni, Eva

AU - Gaipa, Giuseppe

AU - Badolato, Raffaela

AU - Prandini, Alberto

AU - Biondi, Andrea

AU - Ventura, Alessandro

PY - 2015/4/14

Y1 - 2015/4/14

N2 - Mesenchymal stem cells (MSC) are cells of stromal origin which exhibit unlimited self-renewal capacity and pluripotency in vitro. It has recently been observed that MSC may also exert a profound immunosuppressive and anti-inflammatory effect both in vitro and in vivo with consequent potential use in autoimmune disorders. We present the case of a patient suffering from childhood-onset, multidrug resistant and steroiddependent Crohn's disease who underwent systemic infusions of MSC, which led to a temporary reduction in CCR4, CCR7 and CXCR4 expression by T-cells, and a temporary decrease in switched memory B-cells, In addition, following MSC infusion, lower doses of steroids were needed to inhibit proliferation of the patient's peripheral blood mononuclear cells. Despite these changes, no significant clinical benefit was observed, and the patient required rescue therapy with infliximab and subsequent autologous hematopoietic stem cell transplantation. The results of biological and in vitro observations after MSC use and the clinical effects of infusion are discussed, and a brief description is provided of previous data on MSC-based therapy in autoimmune disorders.

AB - Mesenchymal stem cells (MSC) are cells of stromal origin which exhibit unlimited self-renewal capacity and pluripotency in vitro. It has recently been observed that MSC may also exert a profound immunosuppressive and anti-inflammatory effect both in vitro and in vivo with consequent potential use in autoimmune disorders. We present the case of a patient suffering from childhood-onset, multidrug resistant and steroiddependent Crohn's disease who underwent systemic infusions of MSC, which led to a temporary reduction in CCR4, CCR7 and CXCR4 expression by T-cells, and a temporary decrease in switched memory B-cells, In addition, following MSC infusion, lower doses of steroids were needed to inhibit proliferation of the patient's peripheral blood mononuclear cells. Despite these changes, no significant clinical benefit was observed, and the patient required rescue therapy with infliximab and subsequent autologous hematopoietic stem cell transplantation. The results of biological and in vitro observations after MSC use and the clinical effects of infusion are discussed, and a brief description is provided of previous data on MSC-based therapy in autoimmune disorders.

KW - Autoimmune disease

KW - Crohn's disease

KW - Immune regulation

KW - Interferon-γ

KW - Mesenchymal stem cells

KW - Pretreatment

UR - http://www.scopus.com/inward/record.url?scp=84927636027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927636027&partnerID=8YFLogxK

U2 - 10.3748/wjg.v21.i14.4379

DO - 10.3748/wjg.v21.i14.4379

M3 - Article

AN - SCOPUS:84927636027

VL - 21

SP - 4379

EP - 4384

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 14

ER -